BEGIN:VCALENDAR
VERSION:2.0
PRODID:icalendar-ruby
CALSCALE:GREGORIAN
X-WR-CALNAME:Articulating Abortion Series: The History and Future of Aborti
 on Medication in the United States: Reflections on 30 years of Mifepriston
 e
X-WR-TIMEZONE:Eastern Time (US & Canada)
BEGIN:VEVENT
DTSTAMP:20260712T210657Z
UID:tag:localist.com\,2008:EventInstance_42112019380888
DTSTART:20230406T200000Z
DTEND:20230406T210000Z
DESCRIPTION:Since its introduction into clinical practice in France in 1989
 \, the drug mifepristone has been proven safe\, effective\, and cost-effic
 ient for both miscarriage and abortion care\, including self-managed abort
 ion. However\, due to abortion stigma the drug remains subject to excessiv
 e regulations that impose medically unnecessary barriers to use. This talk
  will reflect on the history of this innovation technology and how politic
 al interference has prevented it from having the maximum possible benefit 
 to public health.\n\nElizabeth Janiak\, ScD\, MA\, MSc\, is an Assistant P
 rofessor in the faculties of medicine and public health at Harvard Univers
 ity and a Research Investigator at Brigham and Women's Hospital\, Boston. 
 Situated at the intersection of social epidemiology and health systems res
 earch\, her work focuses on access to abortion and contraception in the Un
 ited States\, promotion of just and patient-centered models of reproductiv
 e health care delivery\, and understanding and ameliorating inequities in 
 reproductive health outcomes.\n\nThis event will take place on April 6 at 
 4pm in room 2-105. This event will be open to the public.
GEO:42.358262;-71.090045
LOCATION:Building 2\, 2-105
SUMMARY:Articulating Abortion Series: The History and Future of Abortion Me
 dication in the United States: Reflections on 30 years of Mifepristone
URL;VALUE=URI:https://calendar.mit.edu/event/articulating_abortion_series_t
 he_history_and_future_of_abortion_medication_in_the_united_states_reflecti
 ons_on_30_years_of_mifepristone
END:VEVENT
END:VCALENDAR
